Skip to content

Esthesioneuroblastoma: Outcomes After Treatment

Esthesioneuroblastoma: Outcomes After Treatment

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02580136
Acronym
ENB
Enrollment
0
Registered
2015-10-20
Start date
2015-09-30
Completion date
2021-02-08
Last updated
2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esthesioneuroblastoma, Olfactory

Keywords

Esthesioneuroblastoma, Tumor, Skull Base Surgery, Sinonasal Cancer

Brief summary

The purpose of this study is to collect and organize data into a repository to gather relevant information for future research from patients diagnosed with a rare malignant sinonasal cancer called esthesioneuroblastoma (ENB) and are scheduled to undergo endonasal skull base surgery. Data being collected includes surgical data, demographics, disease presentation, MRI, CT, PET imaging, and post-operative assessments including pathology tests. After surgery, the investigators will collect chemotherapy and radiation data. Participants will also complete quality of life questionnaires at their follow-up visits.

Interventions

None listed

Sponsors

Ricardo L. Carrau, MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Between the age of 10-80 years * Diagnosed with esthesioneuroblastoma

Exclusion criteria

* Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Quality of Lifeup to 120 months after treatmentAnterior Skull Base (ASB); Skull Base Inventory (SBI); Multidimensional Disease Specific Inventory MDS; ASB-Nasal 12; Sino-Nasal Outcome Test (SNOT-20)
Progression-free survival and overall survivalUp to 120 monthsKaplan-Meier survival curves

Secondary

MeasureTime frame
Length of Hospital Stayup to 120 months
Time spent in operating roomup to 120 months
Number of participants with intraoperative complicationsup to 120 months
Surgical Techniqueup to 120 months
MRI imaging evidence of resectionup to 120 months
Number of participants with postoperative complicationsup to 120 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026